N-glycosylation status of β-haptoglobin in sera of patients with colon cancer, chronic inflammatory diseases and normal subjects

International Journal of Cancer

Volumn 126, Issue 1, 2010, Pages 142-155

  Park, Seung Yeol ^a,b   Yoon, Seon Joo ^b   Jeong, Yeon Tae ^a   Kim, Jin Man ^c   Kim, Ji Yeon ^c   Bernert, Bradford ^d   Ullman, Thomas ^d   Itzkowitz, Steven H ^d   Kim, Jung Hoe ^a   Hakomori, Sen Itiroh ^b,e  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Chungnam National University College of Medicine   (South Korea)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e PNRI   (United States)

Author keywords

Colon cancer; Haptoglobin; HPLC; Lectin blotting; N linked glycan

Indexed keywords

ALPHA LEVO FUCOSIDASE; BETA HAPTOGLOBULIN; EXOGLYCOSIDASE; FLUORESCENT DYE; GLUCOSE; GLYCAN; GLYCOPEPTIDASE; GLYCOSIDASE; HAPTOGLOBIN; LECTIN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HEALTH STATUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN GLYCOSYLATION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; ULCERATIVE COLITIS; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CHRONIC DISEASE; COLONIC NEOPLASMS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOSYLATION; HAPTOGLOBINS; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED;

EID: 73449132942     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24685     Document Type: Article

References (31)

1. Hakomori S. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 1989;52:257-331.
2. Sell S. Serological cancer markersed. Totowa, NJ: Humana Press, 1992.
3. Thompson S, Turner GA. Elevated levels of abnormally-fucosylated haptoglobins in cancer sera. Br J Cancer 1987;56:605-10.
4. Turner GA. N-glycosylation of serum proteins in disease and its investigation using lectins. Clin Chim Acta 1992;208: 149-71.
5. Turner GA. Haptoglobin. A potential reporter molecule for glycosylation changes in disease. Adv Exp Med Biol 1995;376: 231-8.
6. Okuyama N, Ide Y, Nakano M, Nakagawa T, Yamanaka K, Moriwaki K, Murata K, Ohigashi H, Yokoyama S, Eguchi H, Ishikawa O, Ito T, et al. Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int J Cancer 2006;118:2803-8.
7. Nakano M, Nakagawa T, Ito T, Kitada T, Hijioka T, Kasahara A, Tajiri M, Wada Y, Taniguchi N, Miyoshi E. Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: a novel approach for the development of tumor markers. Int J Cancer 2008;122: 2301-9.
8. Royle L, Radcliffe CM, Dwek RA, Rudd PM. Detailed structural analysis of N-glycans released from glycoproteins in SDS-PAGE gel bands using HPLC combined with exoglycosidase array digestions. Methods Mol Biol 2006;347: 125-43.
9. Abd Hamid UM, Royle L, Saldova R, Radcliffe CM, Harvey DJ, Storr SJ, Pardo M, Antrobus R, Chapman CJ, Zitzmann N, Robertson JF, Dwek RA, et al. A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression. Glycobiology 2008;18: 1105-18.
10. Muroi K, Suda T, Nojiri H, Ema H, Amemiya Y, Miura Y, Nakauchi H, Singhal AK, Hakomori S. Reactivity profiles of leukemic myeloblasts with monoclonal antibodies directed to sialosyl-Lex and other lacto-series type 2 chain antigens: absence of reactivity with normal hematopoietic progenitor cells. Blood 1992; 79:713-19.
11. Magnani JL, Nilsson B, Brockhaus M, Zopf D, Steplewski Z, Koprowski H, Ginsburg V. A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. J Biol Chem 1982;257: 14365-9.
12. Yoon S-J, Park S-Y, Pang P-C, Gallagher J, Gottesman JE, Dell A, Kim J-H, Hakomori S. N-glycosylation status of beta-haptoglobin in sera of patients with prostate cancer vs. benign prostate diseases. Int J Oncol, in press.
13. Goodarzi MT, Turner GA. Decreased branching, increased fucosylation and changed sialylation of alpha-L-proteinase inhibitor in breast and ovarian cancer. Clin Chim Acta 1995;236:161-71.
14. Yoon S, Nakayama K, Hikita T, Handa K, Hakomori S. Epidermal growth factor receptor tyrosine kinase is modulated by GM3 interaction with N-linked GlcNAc termini of the receptor. Proc Natl Acad Sci USA 2006;103:18987-91.
15. Johnson SW, Alhadeff JA. Mammalian alpha-L-fucosidases. Comp Biochem Physiol B 1991;99:479-88.
16. Saldova R, Royle L, Radcliffe CM, Abd Hamid UM, Evans R, Arnold JN, Banks RE, Hutson R, Harvey DJ, Antrobus R, Petrescu SM, Dwek RA, et al. Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology 2007; 17: 1344-56.
17. Fujimura T, Shinohara Y, Tissot B, Pang PC, Kurogochi M, Saito S, Arai Y, Sadilek M, Murayama K, Dell A, Nishimura S, Hakomori SI. Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects. Int J Cancer 2008;122:39-49.
18. Hakomori S. Traveling for the glycosphingolipid path. Glycoconjugate J 2000;17:627-47.
19. Ogata S, Muramatsu T, Kobata A. New structural characteristic of the large glycopeptides from transformed cells. Nature 1976;259:580-82.
20. Fernandes B, Sagman U, Auger M, Demetrio M, Dennis JW. b1-6 Branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Res 1991;51:718-23.
21. Seelentag WKF, Li W-P, Schmitz S-FH, Metzger U, Aeberhard P, Heitz PU, Roth J. Prognostic value of b1,6-branched oligosaccharides in human colorectal carcinoma. Cancer Res 1998; 58:5559-64.
22. Kang R, Saito H, Ihara Y, Miyoshi E, Koyama N, Sheng Y, Taniguchi N. Transcriptional regulation of the N-acetylglucosaminyltransferase V gene in human bile duct carcinoma cells (HuCCT1) is mediated by Ets-1. J Biol Chem 1996;271:26706-12.
23. Buckhaults P, Chen L, Freigen N, Pierce M. Transcriptional regulation of N-acetylglucosaminyltransferase V by the src oncogene. J Biol Chem 1997;272: 19575-81.
24. Yoshimura M, Nishikawa A, Ihara Y, Taniguchi S, Taniguchi N. Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection. Proc Natl Acad Sci USA 1995; 92:8754-8.
25. Yoshimura M, Ihara Y, Matsuzawa Y, Taniguchi N. Aberrant glycosylation of E-cadherin enhances cell-cell binding to suppress metastasis. J Biol Chem 1996;271: 13811-15.
26. Hakomori S. Glycosylation defining cancer malignancy: new wine in an old bottle. Proc Natl Acad Sci USA 2002;99:10231-3.
27. Miura Y, Kainuma M, Jiang H, Velasco H, Vogt PK, Hakomori S. Reversion of the Jun-induced oncogenic phenotype by enhanced synthesis of sialosyllactosylceramide (GM3 ganglioside). Proc Natl Acad Sci USA 2004;101: 16204-9.
28. Todeschini AR, Dos Santos JN, Handa K, Hakomori S. Ganglioside GM2/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82/ cMet-mediated pathway. Proc Natl Acad Sci USA 2008;105:1925-30.
29. Mitsuzuka K, Handa K, Satoh M, Arai Y, Hakomori S. A specific microdomain ("glycosynapse 3") controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of alpha3beta1 integrin with CD9. J Biol Chem 2005;280:35545-53.
30. Langlois MR, Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 1996;42:1589-600.
31. Polticelli F, Bocedi A, Minervini G, Ascenzi P. Human haptoglobin structure and function-a molecular modelling study. FEBS J 2008; 275:5648-6.